Aliases & Classifications for Motion Sickness

MalaCards integrated aliases for Motion Sickness:

Name: Motion Sickness 12 41 42 14 69
Travel Sickness 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2951
ICD10 33 T75.3
ICD9CM 35 994.6
MeSH 42 D009041
NCIt 47 C34824
SNOMED-CT via HPO 65 88425004
UMLS 69 C0026603

Summaries for Motion Sickness

MedlinePlus : 41 motion sickness is a common problem in people traveling by car, train, airplanes, and especially boats. anyone can get it, but it is more common in children, pregnant women, and people taking certain medicines. motion sickness can start suddenly, with a queasy feeling and cold sweats. it can then lead to dizziness and nausea and vomiting. your brain senses movement by getting signals from your inner ears, eyes, muscles, and joints. when it gets signals that do not match, you can get motion sickness. for example, if you are reading on your phone while riding a bus, your eyes are focused on something that is not moving, but your inner ear senses motion. where you sit can make a difference. the front seat of a car, forward cars of a train, upper deck on a boat or wing seats in a plane may give you a smoother ride. looking out into the distance - instead of trying to read or look at something in the vehicle - can also help. centers for disease control and prevention

MalaCards based summary : Motion Sickness, also known as travel sickness, is related to space motion sickness and anodontia, and has symptoms including abnormality of the nervous system, abdominal pain and asthenia. An important gene associated with Motion Sickness is HTR3A (5-Hydroxytryptamine Receptor 3A), and among its related pathways/superpathways are Monoamine GPCRs and Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Ondansetron and Histamine have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and testes, and related phenotypes are behavior/neurological and mortality/aging

Wikipedia : 72 Motion sickness, also known as kinetosis and travel sickness, is a condition in which a disagreement... more...

Related Diseases for Motion Sickness

Diseases related to Motion Sickness via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 51)
id Related Disease Score Top Affiliating Genes
1 space motion sickness 12.3
2 anodontia 10.6 HTR1A HTR3A
3 conjunctival degeneration 10.5 HTR1A HTR7
4 scleral staphyloma 10.5 HTR3A HTR7
5 tinea pedis 10.4 HTR1A HTR7
6 luxation of globe 10.4 HTR1A HTR7
7 mandibular cancer 10.3 HTR1A HTR3A
8 abnormal pupillary function 10.3 HTR1A HTR3A HTR7
9 renpenning syndrome 10.3 HTR1A HTR3A HTR7
10 keratosis 10.2 HTR1A HTR7
11 interstitial keratitis 10.2 AQP1 FAM136A
12 autoimmune-related retinopathy and optic neuropathy 10.2 HTR1A HTR3A HTR7
13 autoimmune disease of central nervous system 10.2 FOS HTR7
14 postencephalitic parkinson disease 10.2 HTR1A HTR3A
15 neuronitis 10.1
16 intracranial sinus thrombosis 10.1 AVP HTR3A
17 epileptic encephalopathy, early infantile, 45 10.0 HTR1A HTR3A HTR7
18 prediabetes syndrome 10.0 AQP1 AVP
19 allergic hypersensitivity disease 10.0 FOS HTR1A HTR7
20 acquired aneurysmal subarachnoid hemorrhage 10.0 HTR1A HTR3A TAC1
21 vascular cancer 10.0 FOS HTR1A HTR7
22 personality disorder 10.0 FOS HTR1A HTR7
23 sweat gland cancer 10.0 HTR3A TAC1
24 gnathomiasis 9.9 HTR3A HTR7 TAC1
25 yaws 9.9
26 myositis fibrosa 9.9 HTR3A HTR7 TAC1
27 congenital syphilis 9.8 AVP FAM136A
28 craniosynostosis, adelaide type 9.8 ADRA2A FOS HTR1A
29 scoliosis 9.8
30 idiopathic scoliosis 9.8
31 syncope 9.8
32 viral laryngitis 9.8 AVP FAM136A
33 transsexualism 9.7 FOS HTR1A HTR3A HTR7
34 male reproductive system disease 9.7 AVP FOS
35 semantic agnosia 9.7 FOS HTR7 TAC1
36 cervical adenosarcoma 9.7 FOS HTR7 TAC1
37 orthostatic intolerance 9.7
38 spinal cord injury 9.7
39 thrombosis 9.7
40 cervicitis 9.7
41 plague 9.7
42 retinitis 9.7
43 hyperglycemia 9.7
44 retinal degeneration 9.7
45 mal de debarquement 9.7
46 ataxia 9.7
47 headache 9.7
48 hypoxia 9.7
49 albinism, oculocutaneous, type v 9.6 HTR1A HTR3A HTR7 TAC1
50 palmoplantar keratoderma, bothnian type 9.4 AQP1 AVP

Graphical network of the top 20 diseases related to Motion Sickness:



Diseases related to Motion Sickness

Symptoms & Phenotypes for Motion Sickness

Human phenotypes related to Motion Sickness:

32
id Description HPO Frequency HPO Source Accession
1 abnormality of the nervous system 32 HP:0000707

UMLS symptoms related to Motion Sickness:


abdominal pain, asthenia, body temperature changes, chest pain, constipation, coughing, cyanosis, diarrhea, dyspepsia, edema, eye manifestations, fatigue, fever, flushing, halitosis, headache, heartburn, icterus, nausea and vomiting, oral manifestations, pain, pelvic pain, pruritus, sciatica, signs and symptoms, signs and symptoms, digestive, signs and symptoms, respiratory, skin manifestations, syncope, vertigo, chills, polydipsia, chronic pain, renal colic, vertigo/dizziness, gastrointestinal gas, hot flushes, urological manifestations, symptoms, mobility limitation, prodromal symptoms, hypertriglyceridemic waist, medically unexplained symptoms

MGI Mouse Phenotypes related to Motion Sickness:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.76 ADRA2A AQP1 AVP FOS HTR1A HTR3A
2 mortality/aging MP:0010768 9.56 ADRA2A AQP1 AVP EXT2 FOS HTR1A
3 nervous system MP:0003631 9.17 HTR3A HTR7 ADRA2A AQP1 AVP FOS

Drugs & Therapeutics for Motion Sickness

Drugs for Motion Sickness (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 93)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ondansetron Approved Phase 4 99614-02-5 4595
2
Histamine Approved, Investigational Phase 4,Phase 2,Phase 1 75614-87-8, 51-45-6 774
3
Diphenhydramine Approved Phase 4 58-73-1, 147-24-0 3100
4
Promethazine Approved Phase 4 60-87-7 4927
5
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
6
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
7 Racepinephrine Approved Phase 4
8
Aprepitant Approved, Investigational Phase 4 170729-80-3 151165 6918365
9
Fosaprepitant Approved Phase 4 172673-20-0 219090
10
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
11
Neostigmine Approved, Vet_approved Phase 4 59-99-4 4456
12
Meclizine Approved Phase 4,Phase 2,Phase 1 569-65-3 4034
13
Substance P Investigational Phase 4 33507-63-0 44359816
14 Anti-Anxiety Agents Phase 4
15 Antiemetics Phase 4,Phase 2,Phase 1
16 Antipruritics Phase 4
17 Antipsychotic Agents Phase 4
18 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
19 Central Nervous System Depressants Phase 4
20 Dermatologic Agents Phase 4
21 Gastrointestinal Agents Phase 4,Phase 2,Phase 1
22 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
23 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
24 Psychotropic Drugs Phase 4
25
Serotonin Phase 4 50-67-9 5202
26 Serotonin Agents Phase 4
27 Serotonin Antagonists Phase 4
28 Tranquilizing Agents Phase 4
29 Cholinergic Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
30 Adjuvants, Anesthesia Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
31 Anesthetics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
32 Anti-Allergic Agents Phase 4,Phase 2,Phase 1
33 Bromides Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
34 Butylscopolammonium Bromide Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
35 Cholinergic Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
36 Histamine Antagonists Phase 4,Phase 2,Phase 1
37 Histamine H1 Antagonists Phase 4,Phase 2,Phase 1
38
Histamine Phosphate Phase 4,Phase 2,Phase 1 51-74-1 65513
39 Muscarinic Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
40 Mydriatics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
41 Parasympatholytics Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
42 Scopolamine hydrobromide Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 114-49-8
43 Anesthetics, Local Phase 4
44 Hypnotics and Sedatives Phase 4
45 Epinephryl borate Phase 4
46 glucagon Phase 4
47 Glucagon-Like Peptide 1 Phase 4
48 Hormone Antagonists Phase 4
49 Hormones Phase 4
50 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4

Interventional clinical trials:

(show all 42)

id Name Status NCT ID Phase Drugs
1 A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects Completed NCT02802514 Phase 4 Albiglutide 50mg;Albiglutide matching placebo;Exenatide 10microgram;Exenatide placebo (saline)
2 The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting Completed NCT01897337 Phase 4 Aprepitant;placebo
3 Comparison of the Effects of Neostigmine With Sugammadex on Postoperative Nausea and Vomiting. Completed NCT02286752 Phase 4 Neostigmine;sugammadex
4 Motion Sickness Medications and Vestibular Time Constant Recruiting NCT03270839 Phase 4 Bonine 25Mg Chewable Tablet;Kwells;Placebo Oral Tablet
5 Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels Suspended NCT02136420 Phase 4 Promethazine;Placebo
6 Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria Completed NCT00785135 Phase 3
7 Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray Terminated NCT02155309 Phase 2, Phase 3 Scopolamine;Placebo
8 Levo Phencynonate Hydrochloride for the Prevention of Seasickness Completed NCT02241629 Phase 2 placebo;levo phencynonate hydrochloride
9 Effects of Transdermal Scopolamine on Occupational Performance Completed NCT00374478 Phase 2 Scopolamine
10 Meclizine as a Potential Smoking Cessation Treatment Completed NCT01443858 Phase 2 Meclizine;Nicotine Patch;Placebo
11 Phase II Dose-ranging Study of APD421 in PONV Completed NCT01510704 Phase 2 APD421;Placebo
12 Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV) Completed NCT00895830 Phase 2 APD405;Placebo
13 A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. Completed NCT02839135 Phase 1 Reformulated scopolamine patch;Marketed scopolamine patch
14 Meclizine for Hepatocellular Carcinoma Not yet recruiting NCT03253289 Phase 1 Meclizine Oral Tablet
15 A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness Unknown status NCT01198106 scopolamine;cinnarizine
16 Parabolic Flight Induced Neuroplasticity Studied With Advanced Magnetic Resonance Imaging Methods Unknown status NCT02517216
17 Influence of Gravity on the Perception of Egocentric Distance (Blindpulling) Unknown status NCT02508545
18 Rescue Emetic Therapy for Children Having Elective Surgery Unknown status NCT01067677 Metaclopramide;Ondansetron;diphenhydramine;Saline
19 Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? Completed NCT00360282 Rizatriptan
20 Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers Completed NCT02177890
21 Study of Hierarchy of Afferents in Postural Control of Children With Dyslexia Completed NCT02879786
22 Risk Factors for Post Operative Nausea and Vomiting(PONV) in Patients Underwent Gynecological Operation Under General Anesthesia Completed NCT01020201
23 Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI Completed NCT01379001 Scopolamine;Placebo;Donepezil
24 Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia Completed NCT02416115 Ramosetron;Naloxone;saline;Morphine
25 Virtual Reality Distraction for Procedural Pain Management and Anxiety in Children With Burn Injuries : A Pilot Study Completed NCT02794103
26 Dose of Early Therapeutic Mobility: Does Type or Frequency Matter? Completed NCT00999011
27 Endotoxin-induced Inflammatory and Behavioral Responses and Predictors of Individual Differences Completed NCT02529592
28 The Effects of the Anesthetic Ketamine in Young Children Undergoing Procedural Sedation Completed NCT02650154
29 Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Completed NCT01521728
30 Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation Recruiting NCT02986555
31 Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe Recruiting NCT02911402
32 Risk Factors for Postoperative Nausea, Vomiting and Pruritus Recruiting NCT03178058
33 Effects of Inverted Vision on Pointing and Grasping in Parabolic Flight Recruiting NCT02885844
34 Transcranial Electrical Stimulation for Mal de Debarquement Syndrome Recruiting NCT02540616
35 Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome Recruiting NCT02470377
36 The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression Recruiting NCT02849639 Early Phase 1 Scopolamine patch
37 Influence of Couch Tracking Motion Recruiting NCT02820532
38 Predictive Progressive Factors of Adolescent Idiopathic Scoliosis Recruiting NCT02862392
39 Early Versus Delayed Surgery for Infantile Esotropia Recruiting NCT01166503
40 Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness Recruiting NCT02995811
41 The Effect of Gum Chewing on Postoperative Ileus Withdrawn NCT00879294
42 Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis Withdrawn NCT02830412

Search NIH Clinical Center for Motion Sickness

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: motion sickness

Genetic Tests for Motion Sickness

Anatomical Context for Motion Sickness

MalaCards organs/tissues related to Motion Sickness:

39
Brain, Eye, Testes, Heart, Liver, Skin, Amygdala

Publications for Motion Sickness

Articles related to Motion Sickness:

(show top 50) (show all 610)
id Title Authors Year
1
Orientation Preferences and Motion Sickness Induced in a Virtual Reality Environment. ( 28923138 )
2017
2
Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights. ( 28061915 )
2017
3
Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei. ( 28261089 )
2017
4
Cross-coupling vestibular stimulation: motion sickness and the vestibulo-sympathetic reflex. ( 28455665 )
2017
5
A Historical View of Motion Sickness-A Plague at Sea and on Land, Also with Military Impact. ( 28421029 )
2017
6
Motion sickness increases functional connectivity between visual motion and nausea-associated brain regions. ( 28245927 )
2017
7
Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories. ( 28380077 )
2017
8
Passive restraint reduces visually induced motion sickness in older adults. ( 28150962 )
2017
9
Brain Activation by H1 Antihistamines Challenges Conventional View of Their Mechanism of Action in Motion Sickness: A Behavioral, c-Fos and Physiological Study in Suncus murinus (House Musk Shrew). ( 28659825 )
2017
10
Correlations between individual susceptibility to visually induced motion sickness and decaying time constant of after-nystagmus. ( 28502398 )
2017
11
Determinants of Motion Sickness in Tilting Trains: Coriolis/Cross-Coupling Stimuli and Tilt Delay. ( 28555125 )
2017
12
Storage of passive motion pattern in hippocampal CA1 region depends on CaMKII/CREB signaling pathway in a motion sickness rodent model. ( 28230177 )
2017
13
The efficacy of airflow and seat vibration on reducing visually induced motion sickness. ( 28634889 )
2017
14
Low level of swiprosin-1/EFhd2 in vestibular nuclei of spontaneously hypersensitive motion sickness mice. ( 28128226 )
2017
15
Effect of exposure to short-wavelength light on susceptibility to motion sickness. ( 28538515 )
2017
16
Vestibular evoked myogenic potentials and motion sickness medications. ( 27178852 )
2016
17
Motion Sickness Prediction in Aeromedical Evacuation of Patients with Ebola. ( 26735238 )
2016
18
The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness. ( 27160425 )
2016
19
The virtual reality head-mounted display Oculus Rift induces motion sickness and is sexist in its effects. ( 27915367 )
2016
20
Motion sickness in ancient China: Seasickness and cart-sickness. ( 27432177 )
2016
21
The influence of sleep deprivation and oscillating motion on sleepiness, motion sickness, and cognitive and motor performance. ( 27641791 )
2016
22
Effects of naloxone on motion sickness in cats alone and with broad spectrum antiemetics. ( 27615675 )
2016
23
Motion sickness and sopite syndrome associated with parabolic flights: a case report. ( 26624575 )
2016
24
Psychometric Properties of the Greek Version of the Gianaros Motion Sickness Assessment Questionnaire. ( 27779955 )
2016
25
Subjective Vertical Conflict Theory and Space Motion Sickness. ( 26802378 )
2016
26
Contribution of intra-vestibular sensory conflict to motion sickness and dizziness in migraine disorders. ( 27385797 )
2016
27
Meniere's, migraine, and motion sickness. ( 27918236 )
2016
28
Evaluation of Motion Sickness Induced by 3D Video Clips. ( 26832611 )
2016
29
Moving in a Moving World: A Review on Vestibular Motion Sickness. ( 26913019 )
2016
30
EEG Alpha and Gamma Modulators Mediate Motion Sickness-Related Spectral Responses. ( 26790485 )
2016
31
Motion Sickness and Resting Energy Expenditure in Chinese Male Adults. ( 27026119 )
2016
32
Biodynamic Hypothesis for the Frequency Tuning of Motion Sickness. ( 26735236 )
2016
33
Motion sickness. ( 27638085 )
2016
34
Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility. ( 25910039 )
2015
35
Quantitative orientation preference and susceptibility to space motion sickness simulated in a virtual reality environment. ( 25647233 )
2015
36
Visually induced motion sickness when viewing visual oscillations of different frequencies along the fore-and-aft axis: keeping velocity versus amplitude constant. ( 26280175 )
2015
37
Inter-hemispheric desynchronization of the human MT+ during visually induced motion sickness. ( 26014459 )
2015
38
Three statistical experimental designs for enhancing yield of active compounds from herbal medicines and anti-motion sickness bioactivity. ( 26246716 )
2015
39
Microgravity Simulated by the 6A^ Head-Down Tilt Bed Rest Test Increases Intestinal Motility but Fails to Induce Gastrointestinal Symptoms of Space Motion Sickness. ( 26055239 )
2015
40
Motion sickness is associated with an increase in vestibular modulation of skin but not muscle sympathetic nerve activity. ( 26025612 )
2015
41
EEG based time and frequency dynamics analysis of visually induced motion sickness (VIMS). ( 26462677 )
2015
42
Susceptibility to motion sickness is not increased following spinal cord injury. ( 25882475 )
2015
43
Vection and visually induced motion sickness: how are they related? ( 25941509 )
2015
44
AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat. ( 26651338 )
2015
45
Pathophysiology and treatment of motion sickness. ( 25502048 )
2015
46
Effect of passengers' active head tilt and opening/closure of eyes on motion sickness in lateral acceleration environment of cars. ( 26481809 )
2015
47
Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis. ( 25628336 )
2015
48
Motion Sickness: Current Knowledge and Recent Advance. ( 26452639 )
2015
49
Using bio-signals to evaluate multi discomfort in image viewing - balancing visually induced motion sickness and field of view. ( 26737708 )
2015
50
Visual blur and motion sickness in an optokinetic drum. ( 25945660 )
2015

Variations for Motion Sickness

Expression for Motion Sickness

Search GEO for disease gene expression data for Motion Sickness.

Pathways for Motion Sickness

GO Terms for Motion Sickness

Cellular components related to Motion Sickness according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 8.8 AQP1 HTR3A TAC1

Biological processes related to Motion Sickness according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 signal transduction GO:0007165 9.85 ADRA2A AVP EXT2 HTR1A HTR7
2 sensory perception of pain GO:0019233 9.51 AQP1 TAC1
3 cellular response to hormone stimulus GO:0032870 9.49 ADRA2A FOS
4 positive regulation of epithelial cell migration GO:0010634 9.48 AQP1 TAC1
5 renal water homeostasis GO:0003091 9.43 AQP1 AVP
6 water transport GO:0006833 9.4 AQP1 AVP
7 multicellular organismal water homeostasis GO:0050891 9.37 AQP1 AVP
8 hyperosmotic salinity response GO:0042538 9.32 AQP1 AVP
9 adenylate cyclase-inhibiting serotonin receptor signaling pathway GO:0007198 9.26 HTR1A HTR7
10 insemination GO:0007320 9.16 SEMG1 TAC1
11 positive regulation of saliva secretion GO:0046878 8.96 AQP1 TAC1
12 vasoconstriction GO:0042310 8.8 AVP HTR1A HTR7

Molecular functions related to Motion Sickness according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 neurotransmitter receptor activity GO:0030594 9.16 HTR1A HTR7
2 G-protein coupled serotonin receptor activity GO:0004993 8.96 HTR1A HTR7
3 serotonin binding GO:0051378 8.8 HTR1A HTR3A HTR7

Sources for Motion Sickness

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....